Veno-Venous vs. Veno-Arterial ECMO: Understanding the Differences and Applications

Introduction

Extracorporeal Membrane Oxygenation (ECMO) is a life-support technology used in patients with severe cardiac and/or respiratory failure. The two primary ECMO configurations are Veno-Venous (VV) ECMO and Veno-Arterial (VA) ECMO, each serving distinct clinical purposes (Extracorporeal Life Support Organization (ELSO), 2021). This article explores their differences, applications, and management considerations.

1. Veno-Venous (VV) ECMO

VV ECMO provides respiratory support by oxygenating blood and removing carbon dioxide, allowing the lungs to rest and heal (Sangalli, Patroniti and Pesenti, 2014). It is indicated in cases of severe respiratory failure where mechanical ventilation is insufficient.

Indications for VV ECMO

• Acute Respiratory Distress Syndrome (ARDS) (Combes et al., 2018)
• Severe pneumonia (Schmidt et al., 2020)
• Aspiration pneumonitis (Brogan et al., 2018)
• Near-drowning incidents
• Bridge to lung transplantation

Cannulation Strategy

• Blood drainage: From a central vein (e.g., femoral or internal jugular vein).
• Blood return: To the right atrium via another vein, ensuring systemic oxygenation.
• Cardiac function: The heart continues to pump blood naturally, as VV ECMO does not provide direct cardiac support.

Advantages of VV ECMO

• Preserves native cardiac function
• Avoids complications associated with arterial cannulation
• Lower risk of limb ischemia compared to VA ECMO

2. Veno-Arterial (VA) ECMO

VA ECMO offers both cardiac and respiratory support by bypassing the heart and lungs, maintaining systemic perfusion in patients with severe cardiac failure (Lorusso et al., 2019).

Indications for VA ECMO

• Cardiogenic shock (e.g., post-myocardial infarction, myocarditis) (Barbaro et al., 2020)
• Failure to wean from cardiopulmonary bypass post-cardiac surgery (Makdisi and Wang, 2015)
• Refractory cardiac arrest (ELSO, 2021)
• Massive pulmonary embolism with hemodynamic instability (Lang et al., 2021)
• Toxic drug overdose causing cardiac failure

Cannulation Strategy

• Blood drainage: From a central vein (e.g., femoral vein or right atrium).
• Blood return: Into a central artery (e.g., femoral or aortic artery), directly supporting systemic circulation.
• Cardiac function: The heart is partially or completely bypassed, allowing for myocardial recovery.

Advantages of VA ECMO

• Provides immediate hemodynamic support
• Supports patients with profound cardiac failure
• Can serve as a bridge to heart transplantation or ventricular assist device (VAD) implantation

3. Key Differences Between VV and VA ECMO

4. Choosing Between VV and VA ECMO

The choice between VV and VA ECMO depends on the patient’s underlying condition (Lorusso et al., 2019):

• VV ECMO is preferred for isolated respiratory failure with adequate cardiac function.
• VA ECMO is indicated for patients with significant cardiac failure, with or without respiratory compromise.
• Hybrid configurations (e.g., Veno-Arterial-Venous ECMO) may be considered in cases of combined heart and lung failure (Brogan et al., 2018).

5. Complications and Considerations

Complications of VV ECMO

• Recirculation issues: Mixing of oxygenated and deoxygenated blood, leading to inadequate oxygen delivery (Schmidt et al., 2020).
• Hemolysis: Due to high shear forces within the circuit (Sangalli, Patroniti and Pesenti, 2014).
• Infection risk: From prolonged cannulation (ELSO, 2021).

Complications of VA ECMO

• Increased cardiac afterload: May worsen left ventricular dysfunction (Makdisi and Wang, 2015).
• Limb ischemia: Resulting from arterial cannulation (Lorusso et al., 2019).
• Harlequin Syndrome (North-South Syndrome): Occurs when poorly oxygenated native cardiac output competes with ECMO flow, leading to differential oxygenation (Lang et al., 2021).

6. Recent Guidelines and Case Studies

Guidelines

• The Extracorporeal Life Support Organization (ELSO) provides comprehensive guidelines on ECMO practices, including patient selection, management, and training (ELSO, 2021).
• A 2023 focused update by Japanese cardiovascular societies outlines indications and management strategies for mechanical circulatory support, including ECMO (Yoshihito et al., 2023).

Case Studies

• A case report detailed the successful use of VA-ECMO in a patient who experienced cardiac arrest following endoscopic nasal surgery, highlighting ECMO’s role in unexpected perioperative cardiac events (Kim et al., 2023).
• Another study discussed VA-ECMO support during liver transplantation in a patient with severe pulmonary hypertension and mitral valve stenosis, demonstrating ECMO’s versatility in complex surgical scenarios (Zhu et al., 2023).
• The use of VA-ECMO in a 9-month-old infant with fulminant myocarditis secondary to acute COVID-19 infection underscores ECMO’s application in pediatric patients with severe cardiac involvement (Chen et al., 2023).

7. Conclusion

VV and VA ECMO are pivotal in managing severe respiratory and cardiac failures, respectively. A thorough understanding of their indications, cannulation strategies, and potential complications is essential for optimizing patient outcomes. Continuous education and adherence to updated guidelines are crucial for healthcare professionals involved in ECMO therapy.

References

• Barbaro, R. P. et al. (2020) ‘Extracorporeal membrane oxygenation for COVID-19: ELSO registry experience’, The Lancet Respiratory Medicine, 8(10), pp. 1074–1084.
• Brogan, T. V., Lequier, L., Lorusso, R., MacLaren, G., and Peek, G. (2018) Extracorporeal Life Support: The ELSO Red Book. 5th edn. Ann Arbor, MI: ELSO.
• Chen, Y. et al. (2023) ‘VA-ECMO in pediatric myocarditis: A case study’, Frontiers in Pediatrics, 11, p. 1180534.
• Combes, A. et al. (2018) ‘ECMO for severe ARDS’, New England Journal of Medicine, 378(21), pp. 1965–1975.
• ELSO (2021) ELSO Guidelines for Adult and Pediatric ECMO, Available at: https://www.elso.org.
• Lorusso, R. et al. (2019) ‘Veno-arterial ECMO: Clinical practice and management’, Critical Care, 23, p. 266.
• Sangalli, F., Patroniti, N., and Pesenti, A. (2014) ECMO-Extracorporeal Life Support in Adults. Springer.